Particular targets of interest for ADCs are human epidermal growth factor receptor (EGFR/HER) family of genes (e.g., EGFR, HER2, HER3) [4–7] with an alteration that is often associated with the initiation and maintenance of tumor growth [8]. Here, ERBB2 is linked to neoplasm.